Cardiac Resynchronization Therapy (CRT) in Chronic Heart Failure ; early assessment briefs (Alert)
Swedish Council on Technology Assessment in Health Care
Record ID 32007000265
Swedish
Authors' objectives:
This study aims to assess the patient benefits and costs associated with CRT in treating heart failure.
Authors' recommendations:
Reduced symptoms (Evidence Grade 2), improved quality of life (Evidence Grade 1), and improvement in the severity level of disease (Evidence Grade 1) were found in comparing CRT against pharmacotherapy alone. Furthermore, the results from 2 trials with followup after 12 months showed some reduction in the mortality risk for CRT compared to pharmacotherapy (Evidence Grade 1). The scientific evidence is insufficient to determine the long-term effects and cost effectiveness of the method.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.sbu.se/Published
Year Published:
2007
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Sweden
MeSH Terms
- Cardiac Pacing, Artificial
- Chronic Disease
- Heart Failure
- Pacemaker, Artificial
Contact
Organisation Name:
Swedish Agency for Health Technology Assessment and Assessment of Social Services
Contact Address:
P.O. Box 3657, SE-103 59 Stockholm, Sweden. Tel: +46 8 4123200, Fax: +46 8 4113260
Contact Name:
registrator@sbu.se
Contact Email:
registrator@sbu.se
Copyright:
Swedish Council on Technology Assessment in Health Care (SBU)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.